|1.28||-0.01 / -0.78%|
As of 3:59pm ET
|1.28||0.00 / 0.00%|
The 5 analysts offering 12-month price forecasts for Aevi Genomic Medicine Inc have a median target of 7.00, with a high estimate of 10.00 and a low estimate of 1.50. The median estimate represents a +446.88% increase from the last price of 1.28.
The current consensus among 5 polled investment analysts is to Buy stock in Aevi Genomic Medicine Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.